IP Library › Granted Patent US 9,096,668
Granted Patent B2
US 9,096,668 · App. 13/928,458 · Granted Aug 4, 2015

Methods for making antibody molecules having specificity for human IL-6

Inventors: Richard Evan Gelinas (Seattle, WA); Mitra Choudhury Singhal (Seattle, WA); Yi Zhang (Palo Alto, CA); Andrew George Popplewell (Slough, GB); Ralph Adams (Slough, GB)
Assignee: UCB PHARMA S.A.
C07K16/248A61K2039/505C07K2316/96C07K2317/24C07K2317/34C07K2317/54C07K2317/55C07K2317/565C07K2317/92
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 9,096,668
App. No.
13/928,458
Granted
Aug 4, 2015
Kind
B2
Abstract

The invention relates to antibody molecules having specificity for antigenic determinants of IL-6, therapeutic uses of the antibody molecules and methods for producing said antibody molecules.

Claims (3)

1. A cloning or expression vector comprising DNA comprising nucleotides 58-2008 of SEQ ID NO:15 and nucleotides 61-705 of SEQ ID NO:17.

2. A cultured host cell comprising the cloning or expression vector according to claim 1 .

3. A process for the production of an antibody having binding specificity for human IL-6, comprising culturing a host cell comprising a vector or vectors comprising 1) a DNA encoding the heavy chain of the antibody or variable region thereof, wherein said DNA comprises a sequence selected from the group consisting of SEQ ID NO:12, SEQ ID NO:15, or nucleotides 58-2008 of SEQ ID NO:15 and 2) a DNA encoding the light chain of the antibody or variable region thereof, wherein said DNA comprises a sequence selected from the group consisting of SEQ ID NO:14, SEQ ID NO:17, or nucleotides 61-705 of SEQ ID NO:17, under conditions suitable for the expression of the antibody and isolating the antibody.

Assignments (3)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Mar 8, 2022
From: UCB PHARMA SA
To: R-PHARM INTERNATIONAL LLC
Reel/Frame 059194/0241 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Mar 3, 2022
From: GELINAS, RICHARD EVAN; SINGHAL, MITRA CHOUDHURY; ZHANG, YI; POPPLEWELL, ANDREW GEORGE; ADAMS, RALPH
To: UCB S.A.
Reel/Frame 059159/0081 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Mar 3, 2022
From: UCB S.A.
To: UCB PHARMA S.A.
Reel/Frame 059159/0292 →
Continuity (4)
Continuation 13288260 · Nov 3, 2011
Division 11608408 · Dec 8, 2006
Provisional Application 60748926 · Dec 9, 2005
Related Publication 20140024077A1 · Jan 23, 2014